/Companies

Cytoki Pharma

Værløse, DK · 4 known investors

Find your way into Cytoki Pharma

Sign up to see every warm intro you have to Cytoki Pharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cytoki Pharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cytoki is a biotech company developing IL-22-based therapeutics using lipidation technology to treat metabolic diseases such as obesity and type 2 diabetes, as well as conditions involving epithelial injury like inflammatory bowel disease. It focuses on drug discovery and clinical development for these indications.

Founders & leadership

RJ
Rasmus JorgensenCEO and Founder2019–2026

Investors · 4

Also in the syndicate · 1

Lundbeckfonden Emergelead

Funding

SEC filings, press & company announcements

$45M disclosed across 1 round · 2021

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Cytoki Pharma do?
Cytoki is a biotech company developing IL-22-based therapeutics using lipidation technology to treat metabolic diseases such as obesity and type 2 diabetes, as well as conditions involving epithelial injury like inflammatory bowel disease. It focuses on drug discovery and clinical development for these indications.
Who founded Cytoki Pharma?
Cytoki Pharma was founded by Rasmus Jorgensen.
Who are Cytoki Pharma's investors?
Cytoki Pharma's investors include +ND Capital, Ysios Capital, Seventure Partners.
How much funding has Cytoki Pharma raised?
Cytoki Pharma has disclosed $45M raised across 1 round.
Where is Cytoki Pharma headquartered?
Cytoki Pharma is headquartered in Værløse, DK.